• In-depth content available in Arabic and English developed by global industry experts 
  • Acquired seed funding of $17.5 million in June this year 

Dubai, UAE: selfologi, a Dubai-based digital start-up has launched a first-of-its-kind healthtech website, which enables users to discover and learn about cosmetic treatments in the UAE and KSA.

The new platform provides rich original content on cosmetic treatments allowing users to discover and compare treatments and clinics.

Consumers will now have access to articles and editorial features developed by global industry experts in Arabic and English, detailing everything they need to know to make informed decisions, with confidence. The website will serve as the go-to place for trusted information related to cosmetic treatments from fillers to skin rejuvenation, liposuction to laser hair removal.

According to google search data, more than a million searches are conducted each month on cosmetic treatments in the Middle East. Based on proprietary data, selfologi estimates that over $2.2B worth of cosmetic treatments are taking place across the region annually. However, a huge proportion of the consumers surveyed said that they cannot find the right information to book a treatment online.

In June 2021, selfologi secured $17.5 million in seed funding, led by selfologi’s founder, Tamer Wali and Xenel International group.

“Currently, almost all cosmetic treatments are booked offline, with consumers not having access to updated, regionally-relevant information that can aid their decision-making when it comes to something as personal as cosmetic treatments and procedures. selfologi was born with the vision of offering consumers an unparalleled platform that informs, educates, and helps consumers make the right choice for themselves, and realise their full potential” said Tamer Wali, Founder of selfologi.

Rob Pye, CEO of selfologi added: “At selfologi, we aim to revolutionise the cosmetic and healthtech industry by providing a consumer-centric destination for cosmetic treatments and procedures. With support from the region’s leading experts in aesthetic technologies, alongside some of the best digital brains in the business, selfologi is set to be a game-changer and a pioneer in the multi-billion-dollar cosmetic treatments industry”.

Starting early 2022, users will be able to book cosmetic treatments directly on selfologi.com in the UAE and KSA, with the vision to become the ultimate destination for consumers and cosmetic clinics across the region. Cosmetic clinics and practitioners can join the platform to enhance their visibility and allow clients to book appointments directly online.

Cosmetic treatment professionals can learn more about selfologi at MEIDAM 2021 (Middle East International Dermatology Aesthetic Medicine Conference and Exhibition), taking place September 23-25 at Intercontinental Dubai Festival City.

-Ends-

About selfologi

Based in Dubai, UAE, selfologi is the destination that empowers consumers to discover, learn about, and book cosmetic treatments. The healthtech innovators aim to offer consumers an unparalleled platform that informs, educates, and helps them realise their full potential. selfologi comprises a global team of experts with digital knowledge and a deep understanding of the cosmetic treatments industry. 

For further details please contact:
Feda Kassem
GCI Health Middle East
Feda.kassem@gcihealth.com
+971 04 450 7600

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.